Boston, MA -– Cartagenia, leader in providing clinical genetics and pathology labs with variant assessment & reporting support software, today announced a partnership with Lexington, MA-based N-of-One, an industry-leading provider of patient-specific Clinical Interpretation for molecular profiles at the disease, gene and variant level. With the availability of N-of-One’s services from within the Bench Lab […]
GERMANTOWN, Maryland, and HILDEN, Germany -– QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced today an important expansion of its industry-leading portfolio of liquid biopsies through the acquisition of an innovative technology that enables enrichment and molecular analysis of circulating tumor cells (CTCs) from blood samples. QIAGEN also announced a new partnership with Tokai […]
LEXINGTON, MA –- Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced it had appointed SCRUM, Inc., of Tokyo, Japan, as an exclusive distributor for sales and support of its Simoa technology for the research market in Japan. “We have experienced strong demand […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced that it and its wholly-owned subsidiary, Verinata Health Inc., (together “Illumina”) have filed a patent infringement suit against Premaitha Health plc in the High Court of Justice, Chancery Division, Patents Court in the United Kingdom. Illumina is seeking all available remedies, including damages and injunctive relief. The […]
Boston, MA -– Cartagenia, leader in providing clinical genetics and pathology labs with variant assessment & reporting support software, today announced it is releasing an upgrade of its Bench Lab NGS software platform. The platform now enables labs to implement the recently released ACMG/AMP recommendations for standards and guidelines on the interpretation of sequence variants. […]
NEW YORK -– Enzo Biochem, Inc. (NYSE:ENZ) today announced that the New York State Department of Health has granted conditional approval for Enzo Clinical Labs’ use of the FlowScript™ assay in detection of mRNA from HPV oncogenes, E6 and E7. Overexpression of these HPV oncogenes promotes the growth of malignant cells leading to the development […]
Melbourne-based Genera Biosystems has been testing a HydroSpeed™ plate washer with its Sirocco™ multiplexed diagnostics automation platform, allowing rapid, efficient washing of its proprietary AmpaSand™ beads. Karl Poetter, Chief Scientific Officer, explained: “Following PCR, AmpaSand plates are spun down to remove the supernatant, then washed to remove unbound reagents or PCR products prior to flow […]
OMAHA, Neb. — Transgenomic, Inc. (NASDAQ: TBIO), today announced that it has signed an amended license agreement with Exiqon A/S for the expansion of rights to their proprietary Locked Nucleic Acid (LNA™) oligonucleotides, which offer dramatically improved sensitivity and specificity compared to traditional DNA chemistries. The amended agreement provides Transgenomic with access to LNA oligos […]
SALT LAKE CITY — Myriad RBM, a wholly owned subsidiary ofMyriad Genetics, Inc., (Nasdaq:MYGN) today announced the launch of immunoassay services based on the ultrasensitive Simoa™ (single molecule array) platform developed by Quanterix. The Simoa platform enables the accurate measurement of protein biomarkers that were previously difficult or even impossible to detect in blood samples. […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced the launch of TruSight® HLA, a complete, end-to-end solution that produces a comprehensive view of the HLA region by sequencing 11 HLA genes for accurate HLA typing across thousands of known and novel HLA alleles. Leveraging the MiSeq® Sequencing System, the kit includes the TruSight HLA Sequencing […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
